HDAC3 and Snail2 complex promotes melanoma metastasis by epigenetic repression of IGFBP3

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Epithelial-Mesenchymal Transition (EMT) transcription factors are crucial in cancer development.
• Metastatic melanoma treatment remains a significant clinical challenge.

Purpose of the Study:

• To investigate the role of Snail2 in melanoma progression and metastasis.
• To identify molecular mechanisms underlying Snail2-mediated metastasis and potential therapeutic targets.

Main Methods:

• Analysis of Snail2 expression in melanoma and its correlation with prognosis.
• In vitro and in vivo studies to assess the impact of elevated Snail2 on cell migration and invasion.
• RNA-sequencing (RNA-Seq) to identify genes regulated by Snail2.
• Investigation of the interaction between Snail2, IGFBP3, HDAC3, and the PI3K-AKT pathway.
• In vivo evaluation of combined HDAC3 and p-GSK-3β inhibitors in a melanoma lung metastasis model.

Main Results:

• Snail2 expression is significantly increased in melanoma and linked to poor prognosis.
• Overexpression of Snail2 enhances melanoma cell migration and invasion.
• Snail2 overexpression leads to reduced Insulin-like Growth Factor Binding Protein 3 (IGFBP3) expression.
• Snail2 and Histone Deacetylase 3 (HDAC3) cooperate to suppress IGFBP3 transcription via epigenetic modifications.
• Combined inhibition of HDAC3 and phosphorylated Glycogen Synthase Kinase 3 beta (p-GSK-3β) improved treatment outcomes for lung metastasis.

Conclusions:

• Snail2 is a key driver of melanoma metastasis, potentially through the downregulation of IGFBP3.
• The Snail2-HDAC3-IGFBP3 axis represents a novel regulatory pathway in melanoma progression.
• Targeting Snail2, HDAC3, and IGFBP3, in combination with specific inhibitors, shows therapeutic potential for metastatic melanoma.